Smart Medigap Plans, a Texas-based Medicare Supplement Insurance Agency, has expanded its comprehensive Medicare insurance ...
FDA proposals include ‘major updates’ to simplify biosimilarity studies, reduce unnecessary clinical testing, and ease the process for making biosimilars interchangeable with brand-name biologics.
Lack of OB/GYN care for hyperemesis gravidarum drives pregnant patients to IV spas offering treatment. Experts warn that ...
A Republican Ohio Senator wants to regulate natural kratom products and ban the synthetic version, while Gov. Mike DeWine ...
Several states have banned kratom, an unregulated supplement, that has been linked to six deaths in Los Angeles County ...
A&Z Pharmaceutical Inc. is adding 26,000 square feet of production space to increase the types of generic prescription drugs ...
New capabilities strengthen U.S. production, completing Moderna’s domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
In the first part of his Pharma Commerce video interview, Brad Stewart, BDO’s national life sciences co leader, explains why ...
Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s ...
The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...